Haemophilus influenzae type b vaccine (Hilleman Laboratories)

N/A

Report date: 2025/12/18 17:46:26

Base Information

Drug NameHaemophilus influenzae type b vaccine (Hilleman Laboratories)
Drug Alias Namepolysaccharide conjugated vaccine (Hilleman Laboratories)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHaemophilus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHilleman Laboratories Singapore Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHilleman Laboratories Singapore Pte Ltd
Inactive CompaniesN/A
Active IndicationsHaemophilus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A